HUMA
Humacyte, Inc. · Healthcare
Ayabudge LLC sold $6.1M of Humacyte, Inc.
10% owner
Sold$6,090,000
$4.00Price
1,522,500Shares
−7%Stake
What HUMA did after the filing
- The stock from Mon, Sep 19 close, $3.73
- −7.6%
- S&P 500, same days
- −0.6%
Measured over 30 trading days, to the Oct 31 close.
Traded Thu, Sep 15. Filed Mon, Sep 19, 12:33 PM ET, during the session. Returns use the Sep 19 close and the Oct 31 close. Not investment advice.